Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.

Volume 1 (2004), Issue 3 (November)

1. Azithromycin for cystic fibrosis.
   Eur Respir J, 24(5): 834-8. [Abstract] [Full-text]
2. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles.
   Eur Respir J, 24(5): 798-804. [Abstract] [Full-text]
3. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.
   Thorax, 59(11): 971-6. [Abstract] [Full-text]
4. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.
   Thorax, 59(11): 955-9. [Abstract] [Full-text]
5. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe.
   Thorax, 59(11): 952-4. [Abstract] [Full-text]
6. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
   Thorax, 59(11): 948-51. [Abstract] [Full-text]
7. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis.
   J Pediatr, 145(5): 689-92. [Abstract] [Full-text]
8. Real-time multiple-particle tracking: applications to drug and gene delivery.
   Adv Drug Deliv Rev, 57(1): 63-78. [Abstract] [Full-text]
9. Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis.
   Ann Occup Hyg, 48(8): 673-81. [Abstract] [Full-text]
10. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.
    J Clin Microbiol, 42(11): 5229-37. [Abstract] [Full-text]
11. characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.
    J Clin Microbiol, 42(11): 5176-83. [Abstract] [Full-text]
12. First study of CF mutations in the CFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347H mutations.
    J Trop Pediatr, 50(6): 359-61. [Abstract] [Full-text]
13. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.
    Pharmacotherapy, 24(11): 1641-5. [Abstract] [Full-text]
14. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity.
    BMC Med Genet, 5: 26. [Abstract] [Full-text]
15. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
    Eur J Cardiothorac Surg, 26(6): 1180-6. [Abstract] [Full-text]
16. A comparison of food group variety between toddlers with and without cystic fibrosis.
    J Hum Nutr Diet, 17(6): 523-7. [Abstract] [Full-text]
17. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis.
    J Lipid Res, 45(12): 2277-86. [Abstract] [Full-text]
18. Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis.
    Med Microbiol Immunol (Berl), 193(4): 209-17. [Abstract] [Full-text]
19. Energy balance in cystic fibrosis when stable and during a respiratory exacerbation.
    Clin Nutr, 23(6): 1405-12. [Abstract] [Full-text]
20. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    J Pharmacol Exp Ther, 311(3): 929-38. [Abstract] [Full-text]
21. Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial.
    Thorax, 59(12): 1074-80. [Abstract] [Full-text]
22. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.
    Thorax, 59(12): 1068-73. [Abstract] [Full-text]
23. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
    Mol Ther, 10(6): 990-1002. [Abstract] [Full-text]
24. Trampoline use as physiotherapy for cystic fibrosis patients.
    Pediatr Pulmonol, 39(1): 70-3. [Abstract] [Full-text]
25. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.
    Pediatr Pulmonol, 39(1): 1-4. [Abstract] [Full-text]
26. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Pediatr Pulmonol, 39(1): 15-20. [Abstract] [Full-text]
27. The CLCA gene locus as a modulator of the gastrointestinal basic defect in cystic fibrosis.
    Hum Genet, 115(6): 483-91. [Abstract] [Full-text]
28. The role of pyocyanin in Pseudomonas aeruginosa infection.
    Trends Mol Med, 10(12): 599-606. [Abstract] [Full-text]

© 2004-2008 Cystic Fibrosis Research Today. All Rights Reserved.